Lukatch Heath

Average Profitability
9%
Insider Buys Quantity
1
Insider Buys Sum
$86,020.00
Insider Sells Quantity
18
Insider Sells Sum
$5.97M

Insider Activity of Lukatch Heath

The largest purchase of all time was on 2019-08-15 and amounted to 2000 shares of Inogen, Inc. for $86,020.

The largest sale of all time was on 2017-05-26 and amounted to 14492 shares of Inogen, Inc. for $1.28M.

Biography of Lukatch Heath

No biography is available at this moment.

2024-01-31SaleVaxcyte, Inc.
PCVX
director
5,000
0.0056%
$71.50$357,500+11.01%
2024-01-29SaleVaxcyte, Inc.
PCVX
director
4,000
0.0042%
$67.50$270,000+15.34%
2024-01-02SaleVaxcyte, Inc.
PCVX
director
13,000
0.0139%
$63.76$828,915+21.77%
2023-01-10SaleVaxcyte, Inc.
PCVX
director
315
0.0004%
$46.12$14,526+5.4%
2022-12-12SaleVaxcyte, Inc.
PCVX
director
335
0.0005%
$43.93$14,717+8.33%
2022-11-10SaleVaxcyte, Inc.
PCVX
director
4,335
0.0069%
$46.13$199,989+4.76%
2022-10-26SaleVaxcyte, Inc.
PCVX
director
4,000
0.0058%
$38.25$153,000+14.14%
2019-08-15PurchaseInogen, Inc.
INGN
director
2,000
0.0092%
$43.01$86,020+9%
2018-11-06SaleInogen, Inc.
INGN
director
500
0.0024%
$193.97$96,987-61.7%
2018-10-05SaleInogen, Inc.
INGN
director
500
0.0024%
$218.23$109,115-57.99%
2018-09-06SaleInogen, Inc.
INGN
director
500
0.0024%
$261.54$130,770-62.83%
2018-08-06SaleInogen, Inc.
INGN
director
500
0.0023%
$210.87$105,434-38.79%
2018-07-06SaleInogen, Inc.
INGN
director
1,000
0.0047%
$193.66$193,660-27.17%
2018-06-06SaleInogen, Inc.
INGN
director
1,000
0.0047%
$190.58$190,580-24.58%
2018-03-01SaleInogen, Inc.
INGN
director
5,000
0.0239%
$119.15$595,769+45.92%
2017-12-01SaleInogen, Inc.
INGN
director
5,000
0.0248%
$126.40$631,997+40.39%
2017-09-06SaleInogen, Inc.
INGN
director
5,000
0.0239%
$97.44$487,196+28.08%
2017-05-30SaleInogen, Inc.
INGN
director
3,508
0.0169%
$88.30$309,756+32.05%
2017-05-26SaleInogen, Inc.
INGN
director
14,492
0.0708%
$88.57$1.28M+33.39%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.